相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Spatial Distribution Patterns of Clinically Relevant TERT Promoter Mutations in Follicular Thyroid Tumors of Uncertain Malignant Potential Advantages of the Digital Droplet PCR Technique
Martin Hysek et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2021)
Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review
Louise Stoegbauer et al.
NEUROSURGICAL REVIEW (2020)
Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients
C. Ricci et al.
ENDOCRINE PATHOLOGY (2020)
The curious case of Merkel cell carcinoma: epigenetic youth and lack of pluripotency
Emil Chteinberg et al.
EPIGENETICS (2020)
Exploring the Prognostic Role of Ki67 Proliferative Index in Merkel Cell Carcinoma of the Skin: Clinico-Pathologic Analysis of 84 Cases and Review of the Literature
Stefano La Rosa et al.
ENDOCRINE PATHOLOGY (2020)
PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters
Costantino Ricci et al.
MODERN PATHOLOGY (2019)
EPIC-TABSAT: analysis tool for targeted bisulfite sequencing experiments and array-based methylation studies
Julie Krainer et al.
NUCLEIC ACIDS RESEARCH (2019)
TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up
Adam Stenman et al.
ENDOCRINE PATHOLOGY (2019)
Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
Anna Wenger et al.
NEURO-ONCOLOGY (2019)
Genetic profiles of different subsets of Merkel. cell carcinoma show links between combined and pure MCPyV-negative tumors
Michael D. Carter et al.
HUMAN PATHOLOGY (2018)
De novo and secondary anaplastic meningiomas: natural history, prognosis, and the TERT promoter
Brett J. Theeler
NEURO-ONCOLOGY (2018)
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update
Enis Afgan et al.
NUCLEIC ACIDS RESEARCH (2018)
hTERT promoter methylation status in peripheral blood leukocytes as a molecular marker of head and neck cancer progression
Agnieszka Sobecka et al.
JOURNAL OF APPLIED GENETICS (2018)
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma
Kaiji Fan et al.
CLINICAL CANCER RESEARCH (2018)
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Ricardo Leao et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma
Luca Morandi et al.
ENDOCRINE-RELATED CANCER (2017)
PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma
Christina Mitteldorf et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas
Maria del Carmen Gonzalez-Vela et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
Tareq A. Juratli et al.
ONCOTARGET (2017)
CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel
Luca Morandi et al.
CLINICAL EPIGENETICS (2017)
The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis
Kazuya Haraguchi et al.
APMIS (2017)
hTERT promoter methylation in pituitary adenomas
Michaela Koechling et al.
BRAIN TUMOR PATHOLOGY (2016)
Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS
Xin Zhao et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Human telomerase reverse transcriptase regulation by DNA methylation, transcription factor binding and alternative splicing (Review)
Brittany A. Avin et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas
Gina Furtjes et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: A retrospective cohort study
Pedro Castelo-Branco et al.
ONCOTARGET (2016)
The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma
Paul William Harms et al.
CANCER RESEARCH (2015)
Telomerase (TERT) promoter mutations are infrequent in Merkel cell carcinomas
Hye Jin Chung et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population
Hong Zhang et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
Zhaoming Wang et al.
HUMAN MOLECULAR GENETICS (2014)
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins
Xiaoyong Zheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Methylation of the hTERT promoter is frequent in choroid plexus tumors but not of independent prognostic value
Vincent Ruland et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA
Cathy B. Moelans et al.
MODERN PATHOLOGY (2014)
A general framework for parametric survival analysis
Michael J. Crowther et al.
STATISTICS IN MEDICINE (2014)
TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma
Hong Xie et al.
ONCOTARGET (2014)
Global Analysis of DNA Methylation Variation in Adipose Tissue from Twins Reveals Links to Disease-Associated Variants in Distal Regulatory Elements
Elin Grundberg et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Pedro Castelo-Branco et al.
LANCET ONCOLOGY (2013)
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Evan J. Lipson et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Anti-tumor effect of 5-aza-2′-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells
Shuang-Fen Tao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma
Marika Waltari et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas
Sofia Asioli et al.
MODERN PATHOLOGY (2011)
Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational status
Aleodor A. Andea et al.
HUMAN PATHOLOGY (2010)
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system
Bianca D. Lemos et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Positive Regulation of Human Telomerase Reverse Transcriptase Gene Expression and Telomerase Activity by DNA Methylation in Pancreatic Cancer
Alpana Kumari et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
hTERT methylation and expression in gastric cancer
Carolina Oliveira Gigek et al.
BIOMARKERS (2009)
Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing
Katherine E. Varley et al.
NUCLEIC ACIDS RESEARCH (2009)
Further development of flexible parametric models for survival analysis
Paul C. Lambert et al.
STATA JOURNAL (2009)
Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma
Jee-Hye Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
p63 expression as a new prognostic marker in Merkel cell carcinoma
Sofia Asioli et al.
CANCER (2007)
The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3
Cheng Liu et al.
CANCER RESEARCH (2007)
Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres
I Guilleret et al.
EXPERIMENTAL CELL RESEARCH (2003)
MethPrimer: designing primers for methylation PCRs
LC Li et al.
BIOINFORMATICS (2002)
分享论文
